By Professor Andrew David Carr

Journal articles

Tong WWY; Hillman RJ; Kelleher AD; Grulich AE; Carr A, 2014, 'Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults', HIV Medicine, 15, pp. 65 - 76, http://dx.doi.org/10.1111/hiv.12080

Duda SN; Farr AM; Lindegren ML; Blevins M; Wester CW; Wools-Kaloustian K; Ekouevi DK; Egger M; Hemingway-Foday J; Cooper DA; Moore RD; McGowan CC; Nash D; Saphonn V; Saramony S; Han N; Lee MP; Zhang F; Bele V; Pujari S; Merati T; Ramadian O; Yuliana F; Yunihastuti E; Oka S; Takano M; Kajindran A; Kamarulzaman A; Low LL; Sim BLH; Capistrano R; Ditangco R; Kuo LH; Wong WW; Chaiwarith R; Khongpattanayothin M; Kiertiburanakul S; Kotarathititum W; Phanuphak P; Piyavong B; Fou E; Ng OT; Choi JY; Han SH; Carr A; Chuah J; Dickson B; Hoy J; Ji J; Norris R; Templeton D; Watson K; Bendall C; Jiamsakul A; Law MG; McManus H; Durier N; Petersen B; Sohn AH; Rodriguez B; Gill MJ; Saag MS; Mugavero MJ; Willig J; Eron JJ; Napravnik S; Kitahata MM; Crane HM; Drozd DR; Sterling TR; Haas D; Bebawy S; Turner M; Gange SJ; Althoff KN; McKaig RG; Justice AC; Freeman AM; Lent C; Van Rompaey SE; Morton L; McReynolds J; Lober WB; Abraham AG; Lau B; Zhang J; Jing Y; Golub E; Modur S; Wong C; Mendes A; Masys DR; Minor B; Wehbe F; Cahn P; Krolewiecki A; Cesar C; Schechter M; Faulhaber JC; Wolff M, 2014, 'Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia-Pacific, sub-Saharan Africa and the Americas: Results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration', Journal of the International AIDS Society, 17, http://dx.doi.org/10.7448/IAS.17.1.19045

Lee FJ; Tong WWY; Richardson R; Mackenzie N; Carr A, 2014, 'Metabolic effects of ritonavir-boosted atazanavir and darunavir in HIV-negative adults: A randomised comparison', Journal of AIDS and Clinical Research, 5, http://dx.doi.org/10.4172/2155-6113.1000284

Mcallister J; Read P; Mcnulty A; Tong W; Ingersoll A; Carr A, 2014, 'Raltegravir-emtricitabine-tenofovir as HIV nonoccupational post-exposure prophylaxis in men who have sex with men: Safety, tolerability and adherence', HIV Medicine, 15, pp. 13 - 22, http://dx.doi.org/10.1111/hiv.12075

Bloch M; Tong W; Hoy J; Baker D; Lee F; Richardson R; Carr A, 2014, 'Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks', HIV Medicine, 15, pp. 373 - 380, http://dx.doi.org/10.1111/hiv.12123

Cysique LA; Heaton RK; Kamminga J; Lane T; Gates TM; Moore DM; Hubner E; Carr A; Brew BJ, 2014, 'HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research', Journal of NeuroVirology, 20, pp. 258 - 268, http://dx.doi.org/10.1007/s13365-014-0242-x

Guy R; Wand H; McManus H; Vonthanak S; Woolley I; Honda M; Read T; Sirisanthana T; Zhou J; Carr A, 2013, 'Antiretroviral treatment interruption and loss to follow-Up in Two HIV Cohorts in Australia and Asia: Implications for 'Test and Treat' Prevention Strategy', AIDS Patient Care and Stds, 27, pp. 681 - 691, http://dx.doi.org/10.1089/apc.2012.0439

Worm SW; Bower M; Reiss P; Bonnet F; Law M; Fätkenheuer G; d'Arminio Monforte A; Abrams DI; Grulich A; Fontas E; Kirk O; Furrer H; Wit SD; Phillips A; Lundgren JD; Sabin CA; Butcher D; Delforge M; Fanti I; Franquet X; Geffard S; Gras L; Helweg-Larsen J; Hillebregt M; Kamara D; Kjær J; Krum E; McManus H; Meidahl P; Mocroft A; Nielsen J; Powderl W; Rickenbach M; Rode R; Ryom L; Salbøl Brandt R; Schmidt Iversen J; Shortman N; Sjøl A; Smith C; Torres F; Tverland J; Wright S; Zaheri S; de Wolf F; Smidt J; Ristola M; Katlama C; Viard JP; Girard PM; Livrozet JM; Vanhems P; Pradier C; Dabis F; Neau D; Rockstroh J; Schmidt R; Degen O; van Lunzen J; Stellbrink HJ; Staszewski S; Bogner J; Gargalianos P; Kosmidis J; Perdios J; Xylomenos G; Filandras A; Karabatsaki E; Panos G; Sambatakou H; Banhegyi D; Mulcahy F; Burke M; Turner D; Yust I; Hassoun G; Pollack S; Maayan S; Vella S; Esposito R; Mazeu I; Mussini C; Arici C; Pristera R; Gabbuti A; Mazzotta F; Lichtner M; Vullo V; Boer K; Geerlings SE; Godfried MH; Kuijpers TW; Lange JMA; Nellen FJB; Pajkrt D; Prins JM; Scherpbier HJ; Vrouenraets SME; Wit FWMN; van Vugt M; Cooper D; Petoumenos K; Carr A; Bloch M; Han A, 2013, 'Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study', BMC Infectious Diseases, 13, pp. 471, http://dx.doi.org/10.1186/1471-2334-13-471

Tong WWY; Jin F; McHugh LC; Maher T; Sinclair B; Grulich AE; Hillman RJ; Carr A, 2013, 'Progression to and spontaneous regression of high-grade anal squamous intraepithelial lesions in HIV-infected and uninfected men', AIDS, 27, pp. 2233 - 2243, http://dx.doi.org/10.1097/QAD.0b013e3283633111

Guy R; El-Hayek C; Fairley CK; Wand H; Carr A; McNulty A; Hoy J; Bourne C; McAllister J; Tee BK; Baker D; Roth N; Stoove M; Chen M, 2013, 'Opt-Out and Opt-In Testing Increases Syphilis Screening of HIV-Positive Men Who Have Sex with Men in Australia', PLoS ONE, 8, http://dx.doi.org/10.1371/journal.pone.0071436

Peacock A; Bruno R; Martin FH; Carr A, 2013, 'The Impact of Alcohol and Energy Drink Consumption on Intoxication and Risk-Taking Behavior', Alcoholism Clinical and Experimental Research, 37, pp. 1234 - 1242, http://dx.doi.org/10.1111/acer.12086

Revell AD; Wang D; Wood R; Morrow C; Tempelman H; Hamers RL; Alvarez-Uria G; Streinu-Cercel A; Ene L; Wensing AMJ; DeWolf F; Nelson M; Montaner JS; Lane HC; Larder BA, 2013, 'Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings', Journal of Antimicrobial Chemotherapy, 68, pp. 1406 - 1414, http://dx.doi.org/10.1093/jac/dkt041

Jansson J; Wilson DP; Carr A; Petoumenos K; Boyd MA, 2013, 'Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV', AIDS, 27, pp. 1245 - 1251, http://dx.doi.org/10.1097/QAD.0b013e32835e163d

Peacock A; Martin FH; Carr A, 2013, 'Energy drink ingredients. Contribution of caffeine and taurine to performance outcomes', Appetite, 64, pp. 1 - 4, http://dx.doi.org/10.1016/j.appet.2012.12.021

Mcallister J; Beardsworth G; Lavie E; Macrae K; Carr A, 2013, 'Financial stress is associated with reduced treatment adherence in HIV-infected adults in a resource-rich setting', HIV Medicine, 14, pp. 120 - 124, http://dx.doi.org/10.1111/j.1468-1293.2012.01034.x

Petoumenos K; van Leuwen MT; Vajdic CM; Woolley I; Chuah J; Templeton DJ; Grulich AE; Law MG; Australian HIV Observational Database , 2013, 'Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD).', HIV Med, 14, pp. 77 - 84, http://dx.doi.org/10.1111/j.1468-1293.2012.01038.x

Sasson SC; Oon A; Chagantri J; Brew BJ; Carr A, 2013, 'Posterior reversible encephalopathy syndrome (PRES) in an HIV-1 infected patient with disseminated varicella zoster virus: a case report', BMC Infectious Diseases, 13, pp. 396 - 396, http://dx.doi.org/10.1186/1471-2334-13-396

Lee FJ; Carr A, 2012, 'Tolerability of HIV integrase inhibitors', Current Opinion in HIV and AIDS, 7, pp. 422 - 428, http://dx.doi.org/10.1097/COH.0b013e328356682a

Carr A; Hoy J; Pozniak A, 2012, 'The ethics of switch/simplify in antiretroviral trials: Non-inferior or just inferior?', Plos Medicine, 9, http://dx.doi.org/10.1371/journal.pmed.1001240

Bloch MT; Hoy JF; Cummingham N; Roth N; Bailey M; Pearce D; Watson J; Carr AD, 2012, 'Adherence to HIV treatment guidelines for comorbid disease assessment and inititation of antiretroviral therapy', Journal of Acquired Immune Deficiency Syndrome, 59, pp. 478 - 488, http://dx.doi.org/10.1097/QAI.0b013e31824a5473

Botes LP; Pett SL; Carr AD; Marriott D; Cooper DA; Matthews G; Carbone S; Kumaradevan N; Mchugh L; Hillman R, 2012, 'Anal cytological abnormalities are poor predictors of high-grade intraepithelial neoplasia amongst HIV-positive men who have sex with men.', Sexual Health, 10, pp. 9 - 17, http://dx.doi.org/10.1071/SH11135

Haskelberg H; Hoy J; Amin J; Ebeling PR; Emery S; Carr AD, 2012, 'Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine', PLoS ONE, 7, pp. e38377, http://dx.doi.org/10.1371/journal.pone.0038377

Jansson J; Wilson D; Carr A; Petoumenos K; Boyd M, 2012, 'Currently available medications may not be sufficient for lifelong treatment of HIV', Journal of the International AIDS Society, 15, http://dx.doi.org/10.7448/ias.15.6.18077

Lam UT; Yoganathan R; Carr A; Mammucari R; Foster NR, 2012, 'Encapsulation of superparamagnetic iron oxide nanoparticles by the supercritical antisolvent process', Australian Journal of Chemistry, 65, pp. 40 - 44, http://dx.doi.org/10.1071/CH11360

Koelsch KK, 2012, 'No significant effect of uridine or pravastatin treatment for HIV lip atrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomised trial.', HIV Medicine, 11, pp. 493 - 501

Wright ST; Carr A; Woolley I; Giles M; Hoy J; Cooper DA; Law MG; Australian HIV Observational Database , 2011, 'CD4 cell responses to combination antiretroviral therapy in patients starting therapy at high CD4 cell counts.', J Acquir Immune Defic Syndr, 58, pp. 72 - 79, http://dx.doi.org/10.1097/QAI.0b013e318225ba62

Mcnulty A; Carr A, 2011, 'Approach to those placing others at risk of HIV infection in NSW', Internal Medicine Journal, 41, pp. 365 - 365, http://dx.doi.org/10.1111/j.1445-5994.2011.02462.x

Wand H; Carey D; Calmy A; Law M; Cooper D; Emery S; Carr A, 2011, 'Prospective evidence that HIV lipoatrophy and visceral adiposity are partially independent processes', Open Access Journal of Clinical Trials, 3, pp. 1 - 7, http://dx.doi.org/10.2147/OAJCT.S14359

Haskelberg H; Hoy J; Amin J; Ebeling PR; Emery S; Carr A, 2011, 'Lower fat mass and lower bone formation predict greater bone loss with tenofovir in HIV-infected adults', ANTIVIRAL THERAPY, 16, pp. A6 - A7, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294375900007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hoy J; Grund B; Roediger MP; Brar I; Colebunders R; De Castro N; Johnson M; Sharma A; Carr A, 2011, 'Plasma markers of bone loss and bone formation decrease with intermittent antiretroviral therapy and predict change in bone mineral density', ANTIVIRAL THERAPY, 16, pp. A5 - A6, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294375900006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Carr AG; Mammucari R; Foster NR, 2011, 'A review of subcritical water as a solvent and its utilisation for the processing of hydrophobic organic compounds', Chemical Engineering Journal, 172, pp. 1 - 17, http://dx.doi.org/10.1016/j.cej.2011.06.007

McNulty A; Carr AD, 2011, 'Approach to those placing others at risk of HIV infection in NSW', Internal Medicine Journal, 41, pp. 365 - 365, http://dx.doi.org/10.1111/j.1445-5994.2011.02462.x/pdf

Haskelberg H; Carr AD; Emery S, 2011, 'Bone turnover markers in HIV disease', AIDS Reviews, 13, pp. 240 - 250, http://www.aidsreviews.com/files/2011_13_4_240-250.pdf

Carr AD, 2011, 'eGFR Slope and Tenofovir Nephrotoxicity', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 56, pp. 95 - 96

Hillman R; Pett SL; Marriott D; Carr AD; Cooper DA; Matthews GV; Brew BJ; Milliken S; Botes LP, 2011, 'Participants' perspectives of high resolution anoscopy', Sexual Health, 8, pp. 255 - 256, http://search.informit.com.au/documentSummary;dn=026919938891985;res=IELHEA

Botes LP; Jin F; Bourne CP; Pett SL; Marriott D; Carr AD; Cooper DA; Matthews G; Brew BJ; Hillman R, 2011, 'Participants' perspectives of self-collected anal cytological swabs', Sexual Health, 8, pp. 257 - 258, http://search.informit.com.au/documentSummary;dn=026957204834502;res=IELHEA

Martin A; Amin J; Emery S; Baker D; Carr AD; Cooper DA; Bloch M, 2011, 'Predictors of limb fat gain in HIV positive patients following a change to tenofovir-emtricitabine or Abacavir-Lamivudine', PLoS One, 6, pp. Article number e26885, http://dx.doi.org/10.1371/journal.pone.0026885

Arenas-pinto A; Grant A; Bhaskarin K; Copas A; Carr AD; Worm SW; Martinez E; Reiss P; Dunn ; Weber R; Hoy JF; Weller IV, 2011, 'Risk factors for fatality in HIV-infected patients with dideoxynucleoside-induced severe hyperlactataemia or lactic acidosis', Antiviral Therapy, 16, pp. 219 - 226, http://www.intmedpress.com/journals/addToBasket.cfm?id=1739&sPageURL=%2Fjournals%2Favt%2Farticle.cfm%3Fid%3D1739%26pid%3D88%26sType%3DAVT

O''connor MB; O Connor C; Horgan M; Carr AD; Cooper DA, 2011, 'Sexual activity of HIV patients', Irish Journal of Medical Science, 180, pp. 777 - 779, http://www.springerlink.com/content/h371457w3663647x/

Carr AD, 2011, 'Statins as Anti-inflammatory Therapy in HIV Disease?', Journal of Infectious Diseases, 203, pp. 751 - 752, http://jid.oxfordjournals.org/content/203/6/751

Carr A; Hoy J, 2010, 'Low bone mineral density with tenofovir: Does statistically significant mean clinically significant?', Clinical Infectious Diseases, 51, pp. 973 - 975, http://dx.doi.org/10.1086/656418

Carr AG; Mammucari R; Foster NR, 2010, 'Solubility, solubility modeling, and precipitation of naproxen from subcritical water solutions', Industrial and Engineering Chemistry Research, 49, pp. 9385 - 9393, http://dx.doi.org/10.1021/ie9019825

Wever K; Van Agtmael MA; Carr A, 2010, 'Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men', Journal of Acquired Immune Deficiency Syndromes, 55, pp. 78 - 81, http://dx.doi.org/10.1097/QAI.0b013e3181d05579

Molano M; Tabrizi SN; Garland SM; Roberts JM; MacHalek DA; Phillips S; Chandler D; Hillman RJ; Grulich AE; Jin F; Poynten IM; Templeton DJ; Cornall AM; McCaffery K; Howard K; Farnsworth A; Fairley K; Prestage G; Carr A; Tong W; Law C; Acraman B; Crampton L; Feeney L; Fraissard E; Law M; McGrath P; Mellor R; Norris R; O'Dwyer M; Pendlebury S; Petoumenos K; Richards A; Schema L; Seeds D; Segelov E; Thurloe J; Varma R; Han A, 2010, 'CpG methylation analysis of hpv16 in laser capture microdissected archival tissue and whole tissue sections from high grade anal squamous intraepithelial lesions: A potential disease biomarker', Plos One, 11, pp. e0160673, http://dx.doi.org/10.1371/journal.pone.0160673

Calmy A; Fux CA; Delhumeau C; Carr A, 2010, 'Correspondence : Reply to Gazzola et al', Journal of Infectious Diseases, 202, pp. 331 - 332, http://dx.doi.org/10.1086/653585

Amin J; Martin A; Bloch M; Carr A, 2010, 'Reply to Landman and Soonawala', Clinical Infectious Diseases, 50, pp. 1200 - 1201, http://dx.doi.org/10.1086/651469

Martin A; Amin J; Cooper DA; Carr AD; Kelleher AD; Bloch M; Baker D; Woolley I; Emery S, 2010, 'Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial', AIDS, 24, pp. 2657 - 2663

Bloch M; Hoy J; Cunningham N; Roth N; Andrianopoulos N; Rayner C; Carr A, 2010, 'Adherence to HIV treatment guidelines for initiation of antiretroviral therapy in Australia', Journal of the International AIDS Society, 13, pp. p172 - p172, http://dx.doi.org/10.1186/1758-2652-13-s4-p172

Yan C; Hanafi I; Kelleher AD; Carr AD; Amin J; Mcnally L; Cunningham PH, 2010, 'Lack of correlation between three commerical platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification', Journal of Clinical Virology, 49, pp. 249 - 253

Sinn K; Richardson R; Carr AD, 2010, 'Lower arterial stiffness and framingham score after switching abacavir to tenofovir in men at high cardiovascular risk', AIDS, 24, pp. 2403 - 2405

Back to profile page